The federal government is giving a Maryland biotech company $1.6 billion to produce large quantities of a coronavirus vaccine.
The largest federal vaccine contact to date is going to Novavax, which is the fourth company to receive federal funds for large-scale phase three clinical trials and manufacture of a vaccine.
CEO Stanley Erck said he thinks a vaccine could be on the market by the first quarter of next year.
(Copyright (c) 2024 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)